The Influence of Herbal Medicine Ursolic Acid on the Uptake of Rosuvastatin Mediated by OATP1B11a and 5

Overview

Journal Eur J Drug Metab Pharmacokinet

Date 2014 Apr 17

PMID 24736980

Citations 4

Authors

Wen Jin Hua

Wei Xiao Hua

Fu Yong Nan

Wang An Jiang

Chen Yan

Affiliations

Soon will be listed here.

Abstract

Chinese herbal medicines such as hawthorn, salvia, etc., are frequently combined with statins so as to treat cardiovascular diseases more effectively. Chinese herbal medicines contain many kinds of active components, which may have drug-drug interactions with statins. This study aims to explore the effect and mechanism by which ursolic acid affects OATP1B1-mediated transport of rosuvastatin. This study will explore the effect of ursolic acid on OAPT1B1-mediated transport of rosuvastatin in the different cell systems. Given the genetic polymorphisms of OATP1B1, simultaneously, this study will further explore the effect of ursolic acid on OATP1B1 (521T>C)-mediated transport of rosuvastatin. When the concentration of ursolic acid was 1.8 and 18 µM, it showed that ursolic acid significantly inhibits the uptake of rosuvastatin in both OATP1B1*1a-HEK 293T cells and OATP1B1*5-HEK 293T cells. The reduction of OATP1B1*1a transport of rosuvastatin were 34.60 ± 2.99 and 66.08 ± 1.83 %, and for OATP1B1*5 were 34.27 ± 7.08 % and 66.95 ± 1.14 %. Inhibitory parameters of IC50 were 6.25 ± 0.42 and 6.07 ± 0.57 µM, respectively. This study suggests that ursolic acid can affect the uptake of rosuvastatin in hepatocytes by inhibiting the transport of OATP1B1, and gene mutation of OATP1B1 may cause different effects on its transport of rosuvastatin.

Citing Articles

Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective.

Al-Kuraishy H, Al-Gareeb A, Negm W, Alexiou A, El-Saber Batiha G Inflammopharmacology. 2022; 30(5):1493-1501.

PMID: 35922738 PMC: 9362167. DOI: 10.1007/s10787-022-01038-3.

The possible role of ursolic acid in Covid-19: A real game changer.

Al-Kuraishy H, Al-Gareeb A, El-Saber Batiha G Clin Nutr ESPEN. 2022; 47:414-417.

PMID: 35063236 PMC: 8724013. DOI: 10.1016/j.clnesp.2021.12.030.

Beneficial Effects of Ursolic Acid and Its Derivatives-Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions.

Erdmann J, Kujacinski M, Wicinski M Nutrients. 2021; 13(11).

PMID: 34836155 PMC: 8622438. DOI: 10.3390/nu13113900.

Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Auxtero M, Chalante S, Abade M, Jorge R, Fernandes A Pharmaceutics. 2021; 13(1).

PMID: 33478035 PMC: 7835864. DOI: 10.3390/pharmaceutics13010124.

References

Toth P, Dayspring T . Drug safety evaluation of rosuvastatin. Expert Opin Drug Saf. 2011; 10(6):969-86. DOI: 10.1517/14740338.2012.626764. View

Obaidat A, Roth M, Hagenbuch B . The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol. 2011; 52:135-51. PMC: 3257355. DOI: 10.1146/annurev-pharmtox-010510-100556. View

Muck W, Mai I, Fritsche L, Ochmann K, Rohde G, Unger S . Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clin Pharmacol Ther. 1999; 65(3):251-61. DOI: 10.1016/S0009-9236(99)70104-9. View

Kalliokoski A, Niemi M . Impact of OATP transporters on pharmacokinetics. Br J Pharmacol. 2009; 158(3):693-705. PMC: 2765590. DOI: 10.1111/j.1476-5381.2009.00430.x. View

Jia Y, Bhuiyan M, Jun H, Lee J, Hoang M, Lee H . Ursolic acid is a PPAR-α agonist that regulates hepatic lipid metabolism. Bioorg Med Chem Lett. 2011; 21(19):5876-80. DOI: 10.1016/j.bmcl.2011.07.095. View

Zhang W, Yu B, He Y, Fan L, Li Q, Liu Z . Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin Chim Acta. 2006; 373(1-2):99-103. DOI: 10.1016/j.cca.2006.05.010. View

Gui C, Obaidat A, Chaguturu R, Hagenbuch B . Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr Chem Genomics. 2010; 4:1-8. PMC: 2864424. DOI: 10.2174/1875397301004010001. View

Kim K, Lee J, Park H, Kim J, Kim C, Shim I . Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci. 2004; 74(22):2769-79. DOI: 10.1016/j.lfs.2003.10.020. View

Hua W, Hua W, Fang H . The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins. Cardiovasc Ther. 2011; 30(5):e234-41. DOI: 10.1111/j.1755-5922.2011.00290.x. View

10.

Seglen P . Preparation of isolated rat liver cells. Methods Cell Biol. 1976; 13:29-83. DOI: 10.1016/s0091-679x(08)61797-5. View

11.

Kitamura S, Maeda K, Wang Y, Sugiyama Y . Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin. Drug Metab Dispos. 2008; 36(10):2014-23. DOI: 10.1124/dmd.108.021410. View

12.

Wen J, Xiong Y . The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats. Eur J Drug Metab Pharmacokinet. 2011; 36(4):205-11. DOI: 10.1007/s13318-011-0048-7. View

13.

Kameyama Y, Yamashita K, Kobayashi K, Hosokawa M, Chiba K . Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics. 2005; 15(7):513-22. DOI: 10.1097/01.fpc.0000170913.73780.5f. View

14.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

15.

Choi M, Shin H, Choi Y, Deng J, Shin J, Song I . Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. Xenobiotica. 2010; 41(1):24-34. DOI: 10.3109/00498254.2010.523736. View

16.

Sui S, Wen J, Li X, Xiong Y . [Effect of OATP1B1 521T --> C heterogenesis on pharmacokinetic characterstics of rosuvastatin in Chinese volunteers]. Yao Xue Xue Bao. 2011; 46(6):695-700. View

17.

Choi J, Lee M, Cho J, Lee J, Kim K, Park K . Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans. Clin Pharmacol Ther. 2007; 83(2):251-7. DOI: 10.1038/sj.clpt.6100267. View

18.

Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y . Impact of drug transporter studies on drug discovery and development. Pharmacol Rev. 2003; 55(3):425-61. DOI: 10.1124/pr.55.3.1. View

19.

Jemnitz K, Veres Z, Tugyi R, Vereczkey L . Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes. Toxicol In Vitro. 2009; 24(2):605-10. DOI: 10.1016/j.tiv.2009.10.009. View

20.

Seithel A, Eberl S, Singer K, Auge D, Heinkele G, Wolf N . The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Dispos. 2007; 35(5):779-86. DOI: 10.1124/dmd.106.014407. View

The Influence of Herbal Medicine Ursolic Acid on the Uptake of Rosuvastatin Mediated by OATP1B1*1a and *5

The Influence of Herbal Medicine Ursolic Acid on the Uptake of Rosuvastatin Mediated by OATP1B11a and 5